Morphological features of TMPRSS2–ERG gene fusion prostate cancer No conflicts of interest were declared.
Mosquera, J-M.; Perner, Sven; Demichelis, F.; Kim, R.; Hofer, M. D.; Mertz, K. D.; Paris, P. L.; Simko, J.; Collins, C.; Bismar, T. A.; Chinnaiyan, Arul M.; Rubin, Mark A.
2007-05
Citation
Mosquera, J-M; Perner, S; Demichelis, F; Kim, R; Hofer, MD; Mertz, KD; Paris, PL; Simko, J; Collins, C; Bismar, TA; Chinnaiyan, AM; Rubin, MA (2007)."Morphological features of TMPRSS2–ERG gene fusion prostate cancer No conflicts of interest were declared. ." The Journal of Pathology 212(1): 91-101. <http://hdl.handle.net/2027.42/56053>
Abstract
The TMPRSS2–ETS fusion prostate cancers comprise 50–70% of the prostate-specific antigen (PSA)-screened hospital-based prostate cancers examined to date, making it perhaps the most common genetic rearrangement in human cancer. The most common variant involves androgen-regulated TMPRSS2 and ERG , both located on chromosome 21. Emerging data from our group and others suggests that TMPRSS2–ERG fusion prostate cancer is associated with higher tumour stage and prostate cancer-specific death. The goal of this study was to determine if this common somatic alteration is associated with a morphological phenotype. We assessed 253 prostate cancer cases for TMPRSS2–ERG fusion status using an ERG break-apart FISH assay. Blinded to gene fusion status, two reviewers assessed each tumour for presence or absence of eight morphological features. Statistical analysis was performed to look for significant associations between morphological features and TMPRSS2–ERG fusion status. Five morphological features were associated with TMPRSS2–ERG fusion prostate cancer: blue-tinged mucin, cribriform growth pattern, macronucleoli, intraductal tumour spread, and signet-ring cell features, all with p -values < 0.05. Only 24% ( n = 30/125) of tumours without any of these features displayed the TMPRSS2–ERG fusion. By comparison, 55% ( n = 38/69) of cases with one feature (RR = 3.88), 86% ( n = 38/44) of cases with two features (RR = 20.06), and 93% ( n = 14/15) of cases with three or more features (RR = 44.33) were fusion positive ( p < 0.001). To our knowledge, this is the first study that demonstrates a significant link between a molecular alteration in prostate cancer and distinct phenotypic features. The strength of these findings is similar to microsatellite unstable colon cancer and breast cancer involving BRCA1 and BRCA2 mutations. The biological effect of TMPRSS2–ERG overexpression may drive pathways that favour these common morphological features that pathologists observe daily. These features may also be helpful in diagnosing TMPRSS2–ERG fusion prostate cancer, which may have both prognostic and therapeutic implications. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Publisher
John Wiley & Sons, Ltd.
ISSN
0022-3417 1096-9896
Other DOIs
PMID
17385188
Types
Article
URI
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17385188&dopt=citationMetadata
Show full item recordCollections
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.